Gene Expression in Inflammatory Bowel Disease

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT01171872
Status
Enrolling By Invitation

Conditions

  • Inflammatory Bowel Disease

Eligibility Criteria

Sex
ALL
Age
7 Years - N/A
Healthy Volunteers
Accepted

Study Details

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This protocol is aimed at obtaining tissue samples to test for expression of genes associated with IBD and to better understand the pathogenesis of IBD with the study of genetics, proteomics, physiologic processes and microbiomes (microbiology).

Key Dates

Start date
Nov 30, 1999
Status verified
Jan 2026
Primary completion
Dec 31, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
1,100 participants (estimated)

Arms

  • Arm: Unaffected
    Individuals who do not have IBD
  • Arm: Affected
    Individuals who have IBD

Primary Outcome Measure

Gene Expression in IBD [ Time Frame: Single visit, approximately 1 hour ]

Locations (1)

FacilityCityStateZIPSite coordinators
Johns Hopkins University School of MedicineBaltimoreMaryland21231-

Find similar trials in Baltimore, MD

By research site
Johns Hopkins University School of Medicine· Baltimore, MD

Related Studies